243 related articles for article (PubMed ID: 30884114)
1. Vascular smooth muscle cell-specific progerin expression in a mouse model of Hutchinson-Gilford progeria syndrome promotes arterial stiffness: Therapeutic effect of dietary nitrite.
Del Campo L; Sánchez-López A; Salaices M; von Kleeck RA; Expósito E; González-Gómez C; Cussó L; Guzmán-Martínez G; Ruiz-Cabello J; Desco M; Assoian RK; Briones AM; Andrés V
Aging Cell; 2019 Jun; 18(3):e12936. PubMed ID: 30884114
[TBL] [Abstract][Full Text] [Related]
2. Vascular Smooth Muscle-Specific Progerin Expression Accelerates Atherosclerosis and Death in a Mouse Model of Hutchinson-Gilford Progeria Syndrome.
Hamczyk MR; Villa-Bellosta R; Gonzalo P; Andrés-Manzano MJ; Nogales P; Bentzon JF; López-Otín C; Andrés V
Circulation; 2018 Jul; 138(3):266-282. PubMed ID: 29490993
[TBL] [Abstract][Full Text] [Related]
3. Vascular Smooth Muscle Cell-Specific Progerin Expression Provokes Contractile Impairment in a Mouse Model of Hutchinson-Gilford Progeria Syndrome that Is Ameliorated by Nitrite Treatment.
Del Campo L; Sánchez-López A; González-Gómez C; Andrés-Manzano MJ; Dorado B; Andrés V
Cells; 2020 Mar; 9(3):. PubMed ID: 32182706
[TBL] [Abstract][Full Text] [Related]
4. Defective extracellular pyrophosphate metabolism promotes vascular calcification in a mouse model of Hutchinson-Gilford progeria syndrome that is ameliorated on pyrophosphate treatment.
Villa-Bellosta R; Rivera-Torres J; Osorio FG; Acín-Pérez R; Enriquez JA; López-Otín C; Andrés V
Circulation; 2013 Jun; 127(24):2442-51. PubMed ID: 23690466
[TBL] [Abstract][Full Text] [Related]
5. Premature Vascular Aging with Features of Plaque Vulnerability in an Atheroprone Mouse Model of Hutchinson-Gilford Progeria Syndrome with
Nevado RM; Hamczyk MR; Gonzalo P; Andrés-Manzano MJ; Andrés V
Cells; 2020 Oct; 9(10):. PubMed ID: 33049978
[TBL] [Abstract][Full Text] [Related]
6. Identification of mitochondrial dysfunction in Hutchinson-Gilford progeria syndrome through use of stable isotope labeling with amino acids in cell culture.
Rivera-Torres J; Acín-Perez R; Cabezas-Sánchez P; Osorio FG; Gonzalez-Gómez C; Megias D; Cámara C; López-Otín C; Enríquez JA; Luque-García JL; Andrés V
J Proteomics; 2013 Oct; 91():466-77. PubMed ID: 23969228
[TBL] [Abstract][Full Text] [Related]
7. Cardiovascular Progerin Suppression and Lamin A Restoration Rescue Hutchinson-Gilford Progeria Syndrome.
Sánchez-López A; Espinós-Estévez C; González-Gómez C; Gonzalo P; Andrés-Manzano MJ; Fanjul V; Riquelme-Borja R; Hamczyk MR; Macías Á; Del Campo L; Camafeita E; Vázquez J; Barkaway A; Rolas L; Nourshargh S; Dorado B; Benedicto I; Andrés V
Circulation; 2021 Nov; 144(22):1777-1794. PubMed ID: 34694158
[TBL] [Abstract][Full Text] [Related]
8. Paclitaxel mitigates structural alterations and cardiac conduction system defects in a mouse model of Hutchinson-Gilford progeria syndrome.
Macías Á; Díaz-Larrosa JJ; Blanco Y; Fanjul V; González-Gómez C; Gonzalo P; Andrés-Manzano MJ; da Rocha AM; Ponce-Balbuena D; Allan A; Filgueiras-Rama D; Jalife J; Andrés V
Cardiovasc Res; 2022 Jan; 118(2):503-516. PubMed ID: 33624748
[TBL] [Abstract][Full Text] [Related]
9. Exacerbated atherosclerosis in progeria is prevented by progerin elimination in vascular smooth muscle cells but not endothelial cells.
Benedicto I; Carmona RM; Barettino A; Espinós-Estévez C; Gonzalo P; Nevado RM; de la Fuente-Pérez M; Andrés-Manzano MJ; González-Gómez C; Rolas L; Dorado B; Nourshargh S; Hamczyk MR; Andrés V
Proc Natl Acad Sci U S A; 2024 Apr; 121(18):e2400752121. PubMed ID: 38648484
[TBL] [Abstract][Full Text] [Related]
10. Vascular smooth muscle cell loss underpins the accelerated atherosclerosis in Hutchinson-Gilford progeria syndrome.
Hamczyk MR; Andrés V
Nucleus; 2019 Dec; 10(1):28-34. PubMed ID: 30900948
[TBL] [Abstract][Full Text] [Related]
11. Coronary and carotid artery dysfunction and K
Macías Á; Nevado RM; González-Gómez C; Gonzalo P; Andrés-Manzano MJ; Dorado B; Benedicto I; Andrés V
Geroscience; 2024 Feb; 46(1):867-884. PubMed ID: 37233881
[TBL] [Abstract][Full Text] [Related]
12. Progerinin, an Inhibitor of Progerin, Alleviates Cardiac Abnormalities in a Model Mouse of Hutchinson-Gilford Progeria Syndrome.
Kang SM; Seo S; Song EJ; Kweon O; Jo AH; Park S; Woo TG; Kim BH; Oh GT; Park BJ
Cells; 2023 Apr; 12(9):. PubMed ID: 37174632
[TBL] [Abstract][Full Text] [Related]
13. Decreased vascular smooth muscle contractility in Hutchinson-Gilford Progeria Syndrome linked to defective smooth muscle myosin heavy chain expression.
von Kleeck R; Castagnino P; Roberts E; Talwar S; Ferrari G; Assoian RK
Sci Rep; 2021 May; 11(1):10625. PubMed ID: 34012019
[TBL] [Abstract][Full Text] [Related]
14. Nuclear membrane ruptures underlie the vascular pathology in a mouse model of Hutchinson-Gilford progeria syndrome.
Kim PH; Chen NY; Heizer PJ; Tu Y; Weston TA; Fong JL; Gill NK; Rowat AC; Young SG; Fong LG
JCI Insight; 2021 Aug; 6(16):. PubMed ID: 34423791
[TBL] [Abstract][Full Text] [Related]
15. Molecular and Cellular Mechanisms Driving Cardiovascular Disease in Hutchinson-Gilford Progeria Syndrome: Lessons Learned from Animal Models.
Benedicto I; Dorado B; Andrés V
Cells; 2021 May; 10(5):. PubMed ID: 34064612
[TBL] [Abstract][Full Text] [Related]
16. Progerin accelerates atherosclerosis by inducing endoplasmic reticulum stress in vascular smooth muscle cells.
Hamczyk MR; Villa-Bellosta R; Quesada V; Gonzalo P; Vidak S; Nevado RM; Andrés-Manzano MJ; Misteli T; López-Otín C; Andrés V
EMBO Mol Med; 2019 Apr; 11(4):. PubMed ID: 30862662
[TBL] [Abstract][Full Text] [Related]
17. Progressive vascular smooth muscle cell defects in a mouse model of Hutchinson-Gilford progeria syndrome.
Varga R; Eriksson M; Erdos MR; Olive M; Harten I; Kolodgie F; Capell BC; Cheng J; Faddah D; Perkins S; Avallone H; San H; Qu X; Ganesh S; Gordon LB; Virmani R; Wight TN; Nabel EG; Collins FS
Proc Natl Acad Sci U S A; 2006 Feb; 103(9):3250-5. PubMed ID: 16492728
[TBL] [Abstract][Full Text] [Related]
18. Eliminating the synthesis of mature lamin A reduces disease phenotypes in mice carrying a Hutchinson-Gilford progeria syndrome allele.
Yang SH; Qiao X; Farber E; Chang SY; Fong LG; Young SG
J Biol Chem; 2008 Mar; 283(11):7094-9. PubMed ID: 18178963
[TBL] [Abstract][Full Text] [Related]
19. Unique progerin C-terminal peptide ameliorates Hutchinson-Gilford progeria syndrome phenotype by rescuing BUBR1.
Zhang N; Hu Q; Sui T; Fu L; Zhang X; Wang Y; Zhu X; Huang B; Lu J; Li Z; Zhang Y
Nat Aging; 2023 Feb; 3(2):185-201. PubMed ID: 37118121
[TBL] [Abstract][Full Text] [Related]
20. Progerinin, an optimized progerin-lamin A binding inhibitor, ameliorates premature senescence phenotypes of Hutchinson-Gilford progeria syndrome.
Kang SM; Yoon MH; Ahn J; Kim JE; Kim SY; Kang SY; Joo J; Park S; Cho JH; Woo TG; Oh AY; Chung KJ; An SY; Hwang TS; Lee SY; Kim JS; Ha NC; Song GY; Park BJ
Commun Biol; 2021 Jan; 4(1):5. PubMed ID: 33398110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]